Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bielecka Dabrowa, Agata ^a   Michalska Kasiczak, Marta ^a   Gluba, Anna ^a   Ahmed, Ali ^b   Gerdts, Eva ^c   Von Haehling, Stephan ^d   Rysz, Jacek ^a   Banach, MacIej ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c UNIVERSITY OF BERGEN   (Norway)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CYTOKINE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76); PROCOLLAGEN; PROCOLLAGEN TYPE III-N-TERMINAL PEPTIDE;

AGED; BLOOD; COMPLICATION; ECHOCARDIOGRAPHY; ETIOLOGY; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

AGED; BIOMARKERS; CYTOKINES; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROCOLLAGEN; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84924370873     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep08916     Document Type: Article

References (42)

1. Santulli, G. Epidemiology of Cardiovascular Disease in the 21st Century: Updated Numbers and Updated Facts. J Cardiovasc Dis 1, 1-2 (2013).
2. Fang, J., Mensah, G. A., Croft, J. B. & Keenan, N. L. Heart failure related hospitalization in the U.S., 1979 to 2004. J Am Coll Cardiol. 52, 428-434 (2008).
3. ACC/AHA Quideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J AmColl Cardiol 46, e1-e82 (2005).
4. Gerdts, E. et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 9, 809-815 (2008).
5. Tan, Y. T. et al. Abnormal left ventricular function occurs on exercise in welltreated hypertensive subjects with normal resting echocardiography. Heart. 96, 948-955 (2010).
6. Alagiakrishnan, K. et al. Update on diastolic heart failure or heart failure with preserved ejection fraction in the older adults. Ann Med. 45, 37-50 (2013).
7. Hunt, S. A. et al. 2009 Focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119, e391-e479 (2009).
8. Cheng, J. M. et al. Biomarkers of heart failure with normal ejection fraction: a systematic review. Eur J Heart Fail 15, 1350-1362 (2013).
9. Santulli, G. et al. CaMK4 Gene Deletion Induces Hypertension. J AmHeart Assoc. 1, e001081 (2012).
10. Santulli, G., Trimarco, B. & Iaccarino, G. G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev. 20, 5-12 (2013).
11. Gluba, A. et al. An update on biomarkers of heart failure in hypertensive patients. J Hypertens. 30, 1681-1689 (2012).
12. Bielecka-Dabrowa, A. et al. Heart failure biomarkers in patients with dilated cardiomyopathy. Int J Cardiol. 68, 2404-2410 (2013).
13. Mancia, G. et al. Task Force Members. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 31, 1281-357 (2013).
14. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. (9th ed.). Boston: Little, Brown & Co. 253-256 (1994).
15. Campeau, L. Grading of angina pectoris. Circulation. 54, 52-2 3 (1976).
16. Modification of Diet in Renal Disease Study Group. A more accurate accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 130, 461-70 (1999).
17. Lang, R. M. et al. American College of Cardiology Echocardiography Committee; American Heart Association; European Association of Echocardiography, European Society of Cardiology. Recommendations for chamber quantification. Eur J Echocardiogr. 7, 79-108 (2006).
18. Santulli, G. Coronary heart disease risk factors and mortality. JAMA 21, 1137-PMID, 22436947 (2012).
19. Hasegawa, H. et al. Diastolic mitral annular velocity during the development of heart failure. J Am Coll Cardiol. 41, 1590-1597 (2003).
20. Sohn,D.W. et al.Assessment ofmitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic dysfunction. J Am Coll Cardiol 30, 474-480 (1997).
21. Kass, D. A. Bronzwaer, J. G. & Paulus, W. J. What mechanisms underlie diastolic dysfunction in heart failure? Circ Res 94, 1533-1542 (2004).
22. Martos, R. et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 115, 888-895 (2007).
23. van Heerebeek, L. et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117, 43-51 (2008).
24. Martos, R. et al. Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur. J. Heart Fail. 11, 191-197 (2009).
25. Cortés, R. et al. Relationship between myocardial modelling and diastolic function in patients with essential hypertension. Med Clin (Barc). 139, 325-330 (2012).
26. Agriniera, N. et al. Prognostic value of serum PIIINP, MMP1 and TIMP1 levels in hypertensive patients: a community-based prospective cohort study. Fundamental & Clinical Pharmacology 27, 572-580 (2013).
27. Demir, M. et al. Procollagen type I carboxy-terminal peptide shows left ventricular hypertrophy and diastolic dysfunction in hypertensive patients. Cardiovasc Pathol. 16, 69-74 (2007).
28. Plaksej, R. et al. Relation of circulating markers of fibrosis and progression of left and right ventricular dysfunction in hypertensive patients with heart failure. J. Hypertens. 27, 2483-2491 (2009).
29. López, B. et al. Association of Cardiotrophin-1 With Myocardial Fibrosis in Hypertensive Patients With Heart Failure. Hypertension. 63, 483-9 (2014).
30. Barasch, E. et al.Association between elevated fibrosismarkers and heart failure in the elderly: the cardiovascular health study. Circ Heart Fail 2, 303-310 (2009).
31. Wang, T. J. et al. Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.AmHeart J. 15, 291-297 (2007).
32. Nagueh, S. F.,Middleton, K., Kopelen,H., Zoghbi,W. A.& Quinones,M. A.Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressure. J Am Coll Cardiol 30, 1527-1533 (1997).
33. Ha, J.W. et al. Abnormal longitudinal myocardial functional reserve assessed by exercise tissue Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 19, 1314-1319 (2006).
34. Kitzman, D.W., Higginbotham,M. B., Cobb, F. R., Sheikh, K. H. & Sullivan,M. J. Exercise intolerance in patients with heart failure and preserved left ventricular systolic function: failure of the Frank-Starling mechanism. J Am Coll Cardiol. 17, 1065-1072 (1991).
35. Warner, J. G., Jr., Metzger, D. C., Kitzman, D. W., Wesley, D. J. & Little, W. C. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol. 33, 1567-1572 (1993).
36. Chattopadhyay, S. et al. Lack of diastolic reserve in patients with heart failure and normal ejection fraction. Circ Heart Fail. 3, 35-43 (2013).
37. Terzi, S. et al. Tissue Doppler imaging adds incremental value in predicting exercise capacity in patients with congestive heart failure. Heart Vessels 22, 237-244 (2007).
38. Burgess, M. I., Jenkins, C., Sharman, J. E. & Marwick, T. H. Diastolic stress echocardiography: hemodynamic validation and clinical significance of estimation of ventricular filling pressure with exercise. J Am Coll Cardiol 47, 1891-1900 (2006).
39. Tan, Y. T. et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist and longitudinal motion. J Am Coll Cardiol 54, 36-46 (2009).
40. Gerdts, E. et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 49, 311-6 (2007).
41. Szadkowska, I. et al. Left ventricular dysfunction and NT-proBNP levels in patients with one-vessel disease after first ST-elevation myocardial infarction treated with primary coronary angioplasty. Kardiol Pol. 67, 1201-6 (2009).
42. Bielecka-Dabrowa, A., Michalska-Kasiczak, M., Gluba, A., Rysz, J. & Banach, M. Biomarkers and Echocardiographic Predictors of Myocardial Dysfunction in Patients With Hypertension. Circulation. 130(Suppl. 2), A12171 (2014).